Abstract
Cytoskeleton nanomechanics characterizes cancer cell’s physical behaviors such as how it spread and invade. For anticancer drug, cytoskeleton nanomechanics may be a target to inhibit invasiveness and metastasis of cancer cells. Therefore, in vitro assay of cytoskeleton nanomechanics may be used to evaluate the effects of potential anticancer drug on various cancer types. Here, we investigated the effects of tubeimoside I (TBMS I) on human hepatoma (HepG2) cells by using optical magnetic twisting cytometry, a well-established technique for measuring nanomechanics of the F-actin cytoskeleton. TBMS I is a natural compound extracted from a traditional Chinese herbal medicine, and is reported with antitumor effect. In this study, we demonstrated that the cytoskeleton stiffness (G′) of HepG2 cells was affected by TBMS I. G′ exhibited a typical power law with respect to the loading frequency (f), i.e. g∼f α. The magnitude of G′ and the value of exponent (α) of the HepG2 cells decreased consistently with the increase of concentration for TBMS I exposure. In addition, the HepG2 cells responded to TBMS I much faster than the normal liver (L-02) cells. Such alteration of cytoskeleton nanomechanics induced by TBMS I was reported for the first time, which was further corroborated by assays of F-actin cytoskeleton structure and cell migration. Taken together, these results suggest that in vitro assay of cytoskeleton nanomechanics may have a great potential as an additional tool in screening of anticancer drug candidates.
Article PDF
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.Avoid common mistakes on your manuscript.
References
Zhao X. Supplement to the Compendium of Materia Medica, Reprinted from the 1765 Wood-engraved Edition in Chinese Language. Beijing: The People’s Medical Publishing House, 1983. 123
Yu L, Ma R, Wang Y, et al. Potent anti-tumor activity and low toxicity of tubeimoside I isolated from Bolbostemma Paniculatum. Planta Med, 1994, 60: 204–208
Wang Y, Yu L, Zhu J, et al. Studies on antitumor action of extracts of Bolbostemma Paniculatum (Maxim.) Franquet. J Shaanxi Med, 1981, 10: 55–59
Kong F, Zhu D, Xu R, et al. Structural study of tubeimoside I, a constituent of Tu-Bei-Mu. Tetrahedron Lett, 1986, 27: 5765–5775
Hu Z, Ma R D, Yu L J. Effects of tubeimoside I on cell cycle and apoptosis of human myeloblastic leukemia cells (Hl-60). Chin J Clin Oncol, 2003, 30: 163–171
Ma R D, Weng X Y, Yu L J, et al. Apoptosis of human nasopharyngeal carcinoma CNE-2Z cell line induced by tubeimoside I isolated from Bolbostemma Paniculatum. Chin J Cancer, 2003, 22: 806–811
Ma R D, Yu L J, Su W M, et al. Induction of cell cycle arrest and apoptosis by tubeimoside I isolated from Bolbostemma Paniculatum in Hela cells. Chin J Clin Pharmacol Ther, 2004, 9: 261–269
Ma R, Song G, You W, et al. Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin. Cancer Chemother Pharmacol, 2008, 62: 559–568
Wang F, Ma R D, Yu L J. Role of mitochondria and mitochondrial cytochrome C in tubeimoside I-mediated apoptosis of human cervical carcinoma HeLa cell line. Cancer Chemother Pharmacol, 2006, 57: 389–399
Xu Y, Chiu L F, He Q Y, et al. Tubeimoside-I exerts cytotoxicity in Hela cells through mitochondrial dysfunction and endoplasmic reticulum stress pathways. J Proteome Res, 2009, 8: 1585–1593
Lazarides E, Weber K. Actin antibody: The specific visualization of actin filaments in non-muscle cells. Proc Natl Acad Sci USA, 1974, 71: 2268–2272
Durham J T, Herman I M. Inhibition of angiogenesis in vitro: A central role for beta-actin dependent cytoskeletal remodeling. Microvasc Res, 2009, 77: 281–288
Rando O J, Zhao K, Crabtree G R. Searching for a function for nuclear actin. Trends Cell Biol, 2000, 10: 92–97
Fabry B, Maksym G N, Butler J P, et al. Scaling the microrheology of living cells. Phys Rev Lett, 2001, 87: 148102
Fabry B, Maksym G N, Butler J P, et al. Time scale and other invariants of integrative mechanical behavior in living cells. Phys Rev E Stat Nonlin Soft Mat Phys, 68: 041914
Fabry B, Maksym G N, Shore S A, et al. Selected contribution: Time course and heterogeneity of contractile responses in cultured human airway smooth muscle cells. J Appl Physiol, 2001, 91: 986–994
He H B, Tang X F. Advances in biomechanics research of cancer cells. Foreign Med Sci Stomotol, 2004, 31: 273–275
Wang Y, Deng L, Zhong H, et al. Natural plant extract tubeimoside I promotes apoptosis-mediated cell death in cultured human hepatoma (HepG2) cells. Biol Pharm Bull, 2011, 34: 831–838
Wang Y, Deng L, Wang Y, et al. Natural plant extract tubeimoside I induces cytotoxicity via the mitochondrial pathway in human normal liver cells. Mol Med Reports, 2011, 4: 713–718
Chen P P, Dong H T, Chen L, et al. Application of atomic force microscopy to living samples from cells to fresh tissues. Chin Sci Bull, 2009, 54: 2410–2415
Cross S E, Jin Y, Rao J, et al. Nanomechanical analysis of cells from cancer patients. Nat Nanotech, 2007, 2: 780–783
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work.
This article is published with open access at Springerlink.com
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Zhao, H., Wang, Y., Jiang, X. et al. In vitro assay of cytoskeleton nanomechanics as a tool for screening potential anticancer effects of natural plant extract, tubeimoside I on human hepatoma (HepG2) cells. Chin. Sci. Bull. 58, 2576–2583 (2013). https://doi.org/10.1007/s11434-013-5757-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11434-013-5757-7